公司介绍:天津阿斯尔生物科技有限公司的母公司英国RSR有限公司,是一家有40年历史的医疗诊断试剂的开发商和生产商,产品在自身免疫性甲状腺疾病、1型糖尿病、神经免疫和其他自身免疫性疾病诊断中有广泛应用。RSR还为其他医疗诊断试剂制造商提供高质量的试剂。公司产品远销欧盟、美国、日本、中国等海外市场。公司的创始人Dr Bernard Ree Smith联合其他学者首次证实了Graves病患者血清中的长效甲状腺刺激因子(LATS)实质上是特异性靶向TSHR的自身抗体(即TRAb),而TRAb对TSHR的刺激是造成Graves病患者甲状腺功能亢进的病因。这一研究结果促进了*代TRAb体外检测方法的发展,为自身免疫性甲状腺疾病(AITD)的辅助诊断和管理提供依据,并在后来对该抗体的检测研究做出多项里程碑的贡献,因此RSR被授予了三次英国女王奖。长久以来,RSR公司一直致力于抗原抗体在分子水平上相互作用的前沿研究,上百项研究成果在科学会议及重要的学术期刊上发表。The CompanyRSR is a well-established developer producer of medical diagnostics with key applications in autoimmune thyroid disease, type 1 diabetes mellitus, neuroimmunology other autoimmune diseases. RSR also provides high quality reagents fmedical diagnostic manufacturers. The company’s products are exported to overseas markets including the European Union, the USA, Japan China. The company has a long history of cutting edge research in particular on the interaction between autoantigens autoantibodies at the molecular level. These are presented at scientific meetings published in scientific journals.
What does 天津阿斯尔生物科技有限公司 require? Who is 天津阿斯尔生物科技有限公司 hiring? recruitment: 工厂生产类占比最多占53.8%,其次是医疗卫生/美容保健类占38.5%. What education can get in at ? 本科占比最多占61.5%,其次是硕士占23.1%. High education required at ? 硕士占23.1%. Work experience required at ? 不限占比最多占100%. Where are the job locations at ? 天津占比最多占100%. Based on job postings from the past year, for reference only.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows